Covered recipient · General Payments record
AMY HOLLIHAN MOELLER
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$3,510.02
- Reported across 204 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $595.35 | 27 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $143.94 | 6 |
| Novo Nordisk AS | $103.95 | 5 |
| Lilly USA, LLC | $95.57 | 4 |
| Acerta Pharma LLC | $77.20 | 4 |
| PFIZER INC. | $64.40 | 3 |
| Astellas Pharma US Inc | $51.25 | 2 |
| Exact Sciences Corporation | $25.47 | 1 |
| Amgen Inc. | $18.55 | 1 |
| E.R. Squibb & Sons, L.L.C. | $15.02 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $25.49 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105049850 | CMS |
| ABBVIE INC. | $24.58 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105049852 | CMS |
| ABBVIE INC. | $22.61 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105049854 | CMS |
| ABBVIE INC. | $25.70 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105049856 | CMS |
| ABBVIE INC. | $21.31 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105049858 | CMS |
| ABBVIE INC. | $24.25 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105049860 | CMS |
| Amgen Inc. | $18.55 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111654377 | CMS |
| Astellas Pharma US Inc | $16.65 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139356251 | CMS |
| Astellas Pharma US Inc | $34.60 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139391088 | CMS |
| AstraZeneca Pharmaceuticals LP | $23.52 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105656158 | CMS |
| AstraZeneca Pharmaceuticals LP | $20.62 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105695788 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.00 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104497366 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.06 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104530844 | CMS |
| E.R. Squibb & Sons, L.L.C. | $15.02 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101226139 | CMS |
| Exact Sciences Corporation | $25.47 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114792782 | CMS |
| Lilly USA, LLC | $15.86 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136028138 | CMS |
| Lilly USA, LLC | $26.02 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136032436 | CMS |
| Lilly USA, LLC | $22.46 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136032438 | CMS |
| Lilly USA, LLC | $31.23 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136028140 | CMS |
| Novo Nordisk Inc | $19.45 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097098785 | CMS |
| Novo Nordisk Inc | $15.99 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097820701 | CMS |
| Novo Nordisk Inc | $17.16 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096866405 | CMS |
| Novo Nordisk Inc | $26.72 | 11/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097525132 | CMS |
| Novo Nordisk Inc | $24.63 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096704177 | CMS |
| PFIZER INC. | $22.36 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131409622 | CMS |
| PFIZER INC. | $17.90 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131467423 | CMS |
| PFIZER INC. | $24.14 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132126278 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.